Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATAGLU: Atazanavir Switch and Glucose Metabolism in HIV
NCT02102048Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Jan 2009
- Primary completion
- Mar 2014
- Countries
- 1
01
Overview
Open-label trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Sapienza University of Rome. Primary endpoint: Homeostasis Model Assessment-Insulin Resistance at 1 year. Status: unknown.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02102048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02102048.